Latest News
Conference Coverage
Oral anticoagulation ‘reasonable’ in advanced kidney disease with A-fib
Reduced stroke risk, no increase in bleeding in atrial fibrillation and advanced chronic kidney disease.
Feature
HCA is the country’s highest-volume health system
The Nashville, Tenn.–based corporation discharged twice as many patients as any other health system in 2016.
Conference Coverage
Worse survival with cetuximab plus chemo for CRC liver mets
MADRID – Adding cetuximab as either neoadjuvant or adjuvant treatment resulted in significantly worse survival compared with perioperative...
From the Journals
Dabigatran, rivaroxaban linked to slight increase in GI bleeding risk
Overall, the risk of major bleeds associated with NOACs was similar to the risk with conventional anticoagulants.
Latest News
Many years on metformin linked to anemia risk
LISBON – Why cumulative metformin use is associated with an increased risk of anemia is unclear, and needs to be investigated further, according...
From the Journals
Liquid biopsy predicts checkpoint inhibitor response
The overall response rate to immune checkpoint inhibitors was 45% among cancer patients who had more than three variants of unknown significance...
Feature
Ruling: Apologies can’t be used against doctors in court
The Ohio Supreme Court has ruled that apologies by physicians that include an admission of fault cannot be used against them in court, upholding a...
Latest News
HHS Secretary resigns amid flight criticism
Tom Price, MD, resigned his post following scrutiny over his use of private charter planes at taxpayers’ expense.
Conference Coverage
Robot-assisted abdominoperineal resection outperforms open or laparoscopic surgery for rectal cancers
Patients assigned to robotic-assisted surgery had a total complication rate of 10.4%, compared with 18.8% for patients assigned to laparoscopy and...
From the Journals
Long-term specialist care reduces post-RYGB anemia risk
Patients who underwent Roux-en-Y gastric bypass surgery (RYGB) without long-term bariatric specialist follow-up experienced a significantly higher...
Latest News
Adding bortezomib to R-CHOP didn’t improve survival in diffuse large B-cell lymphoma
Could the phase-2 PYRAMID trial’s bortezomib dosing explain the lack of significant benefit?